Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients' Quality of Life: a Prospective, Non-interventional Trial.

导出 OA

翻译打印收藏纠错

第一作者： Martin,Metz

第一单位： Department of Dermatology and Allergy, Allergy-Centre-Charité, Charité-University Hospital Berlin, Berlin, Germany.

作者： Martin,Metz ^[1] ; Karsten,Weller ^[1] ; Claudia,Neumeister ^[2] ; Iñaki,Izquierdo ^[3] ; Rolf-Hasso,Bödeker ^[4] ; Ulrich,Schwantes ^[5] ; Marcus,Maurer ^[1]

作者单位： Department of Dermatology and Allergy, Allergy-Centre-Charité, Charité-University Hospital Berlin, Berlin, Germany. ^[1] Department of Medical Science/Clinical Research, Dr. R. Pfleger GmbH, Bamberg, Germany. ^[2] Department of Clinical Research, Uriach Group, Barcelona, Spain. ^[3] Department of Statistics, Institute for Medical Informatics, University Clinic Giessen, Giessen, Germany. ^[4] Department of Medical Science/Clinical Research, Dr. R. Pfleger GmbH, Bamberg, Germany. ulrich.schwantes@dr-pfleger.de. ^[5]

关键词 Angioedema Chronic spontaneous urticaria (CSU)Chronic urticaria questionnaire on quality of life (CU-Q2oL)Non-interventional study Quality of life (QoL)Rupatadine Urticaria activity score (UAS7)

DOI 10.1007/s13555-015-0089-y

PMID 26591001

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交